Enhancement of thyroid allograft survival following organ culture: II. Induction of recipient peripheral tolerance

Human Immunology

Volumn 52, Issue 2, 1997, Pages 127-137

  Hullett, Debra A ^a,b   Sollinger, Hans W ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b H4/749 CSC ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

ANIMALS; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DNA PRIMERS; GENE EXPRESSION; GRAFT ENHANCEMENT, IMMUNOLOGIC; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HYPERBARIC OXYGENATION; IMMUNE TOLERANCE; MICE; ORGAN CULTURE TECHNIQUES; POLYMERASE CHAIN REACTION; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; THYROID GLAND; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030909692     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(96)00293-5     Document Type: Article

References (64)

1. Finkelman FD: Relationships among antigen presentation, cytokines, immune deviation, and autoimmune disease. J Exp Med 182:279, 1995.
2. Kroemer G, Martinez AC: Mechanisms of self-tolerance. Immunol Today 13:401, 1992.
3. Bloom BR, Modlin RL, Salgame P: Stigma variations: observations on suppressor T cells and leprosy. Ann Rev Immunol 10:453, 1992.
4. Schwartz RH: T cell anergy. Sci Am 62, 1993
5. Schönrich G, Hämmerling GJ: Multiple levels of peripheral tolerance. Immunol Today 14:12, 1992.
6. Jameson SC, Hogquist KA, Bevan MJ: Positive selection of thymocytes. Ann Rev Immunol 13:93, 1995.
7. Nagata S, Golstein P: The Fas death factor. Science 267: 1449, 1995.
8. Munn DH, Pressey J, Beall AC, Hudes R, Alderson MR: Selective activation-induced apoptosis of peripheral T cells imposed by macrophages. J Immunol 156:523, 1996.
9. Parijs LV, Ibraghimov A, Abbas AK: The roles of costimulation and fas in T cell apoptosis and peripheral tolerance. Immunity 4:321, 1996.
10. Lafferty KJ, Cunningham AJ: A new analysis of allogeneic interactions. Aust J Exp Biol Med Sci 53:27, 1979.
11. Bretcher P, Cohn M: A theory of self-non-self discrimination. Science 169:1042, 1970.
12. Jenkins MK: Relevance of the two signal model of T cell activation to transplantation biology. Transplant Sci 3:33, 1993.
13. Jenkins MK, Schwartz RW: Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 165:302, 1989.
14. Schwartz RH: Costimulation of T lymphocytes: the role of CD28, CTLA-4 and B7/BB1 in IL-2 production and immunotherapy. Cell 71:1065, 1992.
15. Buhlmann JE, Foy TM, Aruffo A, Crassi KM, Ledbetter JA, Green WR, Xu JC, Shultz LD, Roopesian R, Flavell RA, Fast L, Noelle RJ, Durie FH: In the absence of a CD40 signal B cells are tolerogenic. Immunity 2:645, 1995.
16. Freeman GJ, Gribben JG, Boussiotis VA, NgJW, Restivo VAJ, Lombard LA, Gray GS, Nadler LM: Cloning of B7-2: a CTLA-4 counter receptor that co-stimulates human T cell proliferation. Science 262:909, 1993.
17. Thomas JM, Carver FM, Kasten-Jolly J, Haisch CE, Thomas FT: Transplantation tolerance in nonhuman primates: a case for veto cells. Transplant Sci 3:69, 1993.
18. Herber-Katz H: The autoimmune T cell receptor epitopes, idiotopes, and malatopes. Clin Immunol Immunopathol 55:1, 1990.
19. Kumar V, Secarz EE: The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease. J Exp Med 178: 909, 1993.
20. Bushell A, Pearson TC, Morris PJ, Wood KJ: Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor-specific transfusion and anti-CD4 antibody. Transplantation 59:1367, 1995.
21. Qin S, Cobbold SP, Pope H, Elliott J, Kioussiss D, Davies J, Waldmann H: "Infectious" transplantation tolerance. Science 259:974, 1993.
22. Liblau RS, Singer SM, McDevitt HO: Th1 and Th2 Cd4+ T cells in the pathogenesis of organ-specific auto-immune diseases. Immunol Today 16:34, 1995.
23. Heinsel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM: Reciprocal expression of Interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. J Exp Med 169:59, 1994.
24. Ando DG, Clayton J, Kono D, Urban JL, Sercarz EE: Encephalitiogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cellular Immunol 124:132, 1989.
25. Rapaport MJ, Jaramillo A, Zipris D, Lazanus AH, Serreze DV, Leiter EH, Cyopick P, Dansko JS, Delovitch TL: IL-4 reverses T-cell proliferative unresponsiveness and prevents the onset of diabetes in NOD mice. J Exp Med 178:87, 1993.
26. Talmage DW, Dart GA: Effect of oxygen pressure during culture on survival of mouse thyroid allografts. Science 200:1066, 1978.
27. Lafferty KJ, Bootes A, Kilby AA, Barch W: Mechanism of thyroid allograft rejection. Aust Exp Biol Sci 54:573, 1976.
28. LaRosa FB, Talmage DW: The failure of a major histocompatibility antigen to stimulate a thyroid allograft reaction after culture in oxygen. J Exp Med 157:898, 1983.
29. Hardy MA, Reemtsma K, Lau HT: Induction of indefinite rat islet allograft survival with direct ultraviolet irradiation and peri-transplant cyclosporine. Transplant Proc 17: 423, 1985.
30. Markmann JF, Tomaszewski J, Posselt AN, Levy AR, Woehrle M, Barker CF, Naji A: The effect of islet cell culture in vitro at 24°C on graft survival and MHC antigen expression. Transplantation 49:272, 1990.
31. Lafferty KJ, Prowse SJ, Simeonovic CJ: Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol. 1:143, 1983.
32. LaRosa FG, Smilek D, Talmage DW, Lafferty KJ, Bauling P, Ammons TJ: Evidence that tolerance to cultured thyroid allografts is an active immunological process. Protection of third party grafts bearing new antigens when associated with tolerogenic antigens. Transplantation 53: 903, 1992.
33. Talmage DW, La Rosa FG, Smilek D, Ammons TJ: The tolerance that develops in recipients of cultured allografts is an active process that affects both the activation and effector function of cytolytic T cells. In Meryman HT (ed.): Transplantation: approaches to graft rejection. New York, Liss, 1986, p 187.
34. Hullett DA, Landry AS, Leonard DK, Sollinger HW: Enhancement of thyroid allograft survival following organ culture: alteration of tissue immunogenicity. Transplantation 47:24, 1989.
35. Hullett DA, Landry AS, Sollinger HW: Mechanism of modification of allograft antigenicity. Transplant Proc 22: 1928, 1990.
36. In vitro assays for mouse lymphocyte function. In Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, and Strober W (eds.): Current Protocols in Immunology. New York, Wiley Interscience, 1992, p 3111.
37. Orosz CG, Bishop DK, Ferguson RM: In vitro mechanisms of alloreactivity. VI. Evidence that alloantigen deposition mitiates both local and systemic mechanisms that influence CTL accumulation at a graft site. Transplantation 48:818, 1989.
38. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987.
39. Kawasaki ES: Amplification of RNA. In: Innis et al., eds. PCR Protocols, A Guide to Methods and Applications. San Diego, CA, Academic Press, Inc., 1991, p 21.
40. Brenner CA, Tom AW, Nelson PA, Engleman EG, Suzuki N, Fry KE, Larrick JW: Message amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells. Biotechniques. 7(10):1096, 1989.
41. Shinkai Y, Takio K, Okumura K: Homology of perforin to the ninth component of complement (ca). Nature 334: 535, 1988.
42. Coulombe M, Gill RG: Tolerance Induction to Cultured Islet Allografts. I. Characterization of the tolerant state. Transplantation 57:1195, 1994.
43. Coulombe M, Gill RG: Tolerance Induction to Cultured Islet Allografts. II. Status of Anti-Donor Reactivity in Tolerant Animals. Transplantation 57:1201, 1994.
44. Donohoe JA, Andrus L, Bowen KM, Simeonovic C, Prowse SJ, Lafferty KJ: Cultured thyroid allografts induce a state of partial tolerance in adult recipient mice. Transplantation 35:62, 1983.
45. Wood KJ: The induction of immunological unresponsiveness to alloantigen using transfected cells. Transplant Sci 3:56, 1993.
46. Shoskes DA, Wood KJ: Indirect presentation of MHC antigens in transplantation. Immunol Tod 15:32, 1994.
47. Saitovitch D, Bushell A, Mabbs DW, Morris PJ, Wood KJ: Kinetics of induction of transplantation tolerance with a nondepleting anti-Cd4 monoclonal antibody and donor-specific transfusion before transplantation: a critical period of time is required for development of immunological unresponsiveness. Transplantation 61:1642, 1996.
48. Chen N, Gao Q, Field EH: Prevention of TH1 responses is critical for tolerance. Transplantation 61:1076, 1996.
49. Takeuchi T, Lowry RP, Konieczny B: Heart allografts in murine systems. Transplantation 53:1281, 1992.
50. Mottram PL, Han WR, Purcell LJ, McKenzie IFC, Hancock WW: Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-g in long-surviving mouse heart allografts after brief CD4- monoclonal antibody therapy. Transplantation 59:559, 1995.
51. Sarzotti M, Robbins DS, Hoffman PM: Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 271:1726, 1996.
52. Forsthuber T, Yip HC, Lehmann PV: Induction of TH1 and TH2 immunity in neonatal mice. Science 271:1728, 1996.
53. Pfeiffer C, Stein J, Southwood S, Ketelaar H, Sette A, Bottomly K: Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med 181:1569, 1995.
54. + T cells to protein antigens in vivo. J Immunol 155:3734, 1995.
55. + T cells. J Immunol 154:4915, 1995.
56. + T cells. J Exp Med 182:1591, 1995.
57. Kumar V, Bhardwaj V, Soares L, Alexander J, Sette A, Sercarz E: Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon g by T cells. Proc Natl Acad Sci 92:9510, 1995.
58. Nicholson LB, Greer JM, Sobel RA, Lees MB, Kuchroo VK: An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3:397, 1995.
59. Szabo SJ, Jacobson NG, Dighe AS, Gubler U, Murphy KM. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2:665, 1995.
60. Streilein JW: Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye. Eye 9:236, 1995.
61. Streilein JW, Niederkorn JY, Shadduck JA: Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens. J Exp Med 152:1121, 1980.
62. Kosiewicz M, Streilein JW: Is deviant immunity induced by intraocular injection of antigen dependent on Th2 cells. Invest Opthal and Vis Sci 37:S1135, 1996.
63. Streinlein JW: Abstract Immune privilege, tolerance and tissue-related autoimmunity. The Ray Owen Symposium-Past, Present, and Future. June 21-22, 1996 Madison WI.
64. Wilbanks GA, Streilein JW: Distinctive humoral immune responses following anterior chamber and intravenous administration of soluble antigen. Evidence for active suppression of IgG2-secreting B lymphocytes. Immunol 1990;71:566-572.